Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer’s disease
出版年份 2020 全文链接
标题
Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer’s disease
作者
关键词
-
出版物
Nature Communications
Volume 11, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-04-03
DOI
10.1038/s41467-020-15436-0
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Associations between tau, Aβ, and cortical thickness with cognition in Alzheimer disease
- (2019) Rik Ossenkoppele et al. NEUROLOGY
- The impact of preanalytical variables on measuring cerebrospinal fluid biomarkers for Alzheimer's disease diagnosis: A review
- (2018) Oskar Hansson et al. Alzheimers & Dementia
- NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
- (2018) Clifford R. Jack et al. Alzheimers & Dementia
- Comparing18F-AV-1451 with CSF t-tau and p-tau for diagnosis of Alzheimer disease
- (2018) Niklas Mattsson et al. NEUROLOGY
- Tau Kinetics in Neurons and the Human Central Nervous System
- (2018) Chihiro Sato et al. NEURON
- Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease
- (2018) Lawrence S. Honig et al. NEW ENGLAND JOURNAL OF MEDICINE
- A 2-Step Cerebrospinal Algorithm for the Selection of Frontotemporal Lobar Degeneration Subtypes
- (2018) Alberto Lleó et al. JAMA Neurology
- Current state of Alzheimer’s fluid biomarkers
- (2018) José Luis Molinuevo et al. ACTA NEUROPATHOLOGICA
- Appropriate use criteria for lumbar puncture and cerebrospinal fluid testing in the diagnosis of Alzheimer's disease
- (2018) Leslie M. Shaw et al. Alzheimers & Dementia
- Accurate risk estimation of β-amyloid positivity to identify prodromal Alzheimer's disease: Cross-validation study of practical algorithms
- (2018) Sebastian Palmqvist et al. Alzheimers & Dementia
- Correlation of In Vivo [18F]Flortaucipir With Postmortem Alzheimer Disease Tau Pathology
- (2018) Ruben Smith et al. JAMA Neurology
- Flortaucipir F 18 Quantitation Using Parametric Estimation of Reference Signal Intensity
- (2017) Sudeepti Southekal et al. JOURNAL OF NUCLEAR MEDICINE
- Test–Retest Reproducibility for the Tau PET Imaging Agent Flortaucipir F 18
- (2017) Michael D. Devous et al. JOURNAL OF NUCLEAR MEDICINE
- Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer's disease
- (2017) Anne Maass et al. NEUROIMAGE
- Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity
- (2017) Sebastian Palmqvist et al. Nature Communications
- Concordance Between Different Amyloid Immunoassays and Visual Amyloid Positron Emission Tomographic Assessment
- (2017) Shorena Janelidze et al. JAMA Neurology
- Molecular mechanism of prion-like tau-induced neurodegeneration
- (2016) Alejandra D. Alonso et al. Alzheimers & Dementia
- Characterization of tau positron emission tomography tracer [ 18 F]AV-1451 binding to postmortem tissue in Alzheimer's disease, primary tauopathies, and other dementias
- (2016) Kerstin Sander et al. Alzheimers & Dementia
- In vivo cortical spreading pattern of tau and amyloid in the Alzheimer disease spectrum
- (2016) Hanna Cho et al. ANNALS OF NEUROLOGY
- The relationship between cerebrospinal fluid markers of Alzheimer pathology and positron emission tomography tau imaging
- (2016) Brian A. Gordon et al. BRAIN
- Modeling Strategies for Quantification of In Vivo 18 F-AV-1451 Binding in Patients with Tau Pathology
- (2016) Andreas Hahn et al. JOURNAL OF NUCLEAR MEDICINE
- Alzheimer's disease
- (2016) Philip Scheltens et al. LANCET
- CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis
- (2016) Bob Olsson et al. LANCET NEUROLOGY
- Temporal T807 binding correlates with CSF tau and phospho-tau in normal elderly
- (2016) Jasmeer P. Chhatwal et al. NEUROLOGY
- Tau and Aβ imaging, CSF measures, and cognition in Alzheimer’s disease
- (2016) Matthew R. Brier et al. Science Translational Medicine
- An autoradiographic evaluation of AV-1451 Tau PET in dementia
- (2016) Val J. Lowe et al. Acta Neuropathologica Communications
- Amyloid biomarkers in Alzheimer's disease
- (2015) Kaj Blennow et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- mixtools: AnRPackage for Analyzing Finite Mixture Models
- (2015) Tatiana Benaglia et al. Journal of Statistical Software
- Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
- (2014) Bruno Dubois et al. LANCET NEUROLOGY
- Accuracy of Brain Amyloid Detection in Clinical Practice Using Cerebrospinal Fluid β-Amyloid 42
- (2014) Sebastian Palmqvist et al. JAMA Neurology
- [18F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease
- (2013) Chun-Fang Xia et al. Alzheimers & Dementia
- Preclinical Alzheimer's disease and its outcome: a longitudinal cohort study
- (2013) Stephanie JB Vos et al. LANCET NEUROLOGY
- Cerebrospinal Fluid Levels ofβ-Amyloid 1-42, but Not of Tau, Are Fully Changed Already 5 to 10 Years Before the Onset of Alzheimer Dementia
- (2012) Peder Buchhave ARCHIVES OF GENERAL PSYCHIATRY
- The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Guy M. McKhann et al. Alzheimers & Dementia
- The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Marilyn S. Albert et al. Alzheimers & Dementia
- pROC: an open-source package for R and S+ to analyze and compare ROC curves
- (2011) Xavier Robin et al. BMC BIOINFORMATICS
- Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia
- (2011) Katya Rascovsky et al. BRAIN
- Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohort
- (2011) N. S. M. Schoonenboom et al. NEUROLOGY
- Classification of primary progressive aphasia and its variants
- (2011) M. L. Gorno-Tempini et al. NEUROLOGY
- Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
- (2010) Kaj Blennow et al. Nature Reviews Neurology
- Cerebrospinal Fluid β-Amyloid 42 and Tau Proteins as Biomarkers of Alzheimer-Type Pathologic Changes in the Brain
- (2009) Tero Tapiola et al. ARCHIVES OF NEUROLOGY
- Tau phosphorylation: the therapeutic challenge for neurodegenerative disease
- (2009) Diane P. Hanger et al. TRENDS IN MOLECULAR MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started